2 September 2015 – The next MPAC meeting will take place in Geneva, Switzerland on 16–18 September. The Committee will review the recommendations of expert groups on the use of mass drug administration for malaria; prevention and treatment of malaria in pregnancy; and vector control coverage. It will also hear updates on artemisinin and ACT resistance in the Greater Mekong subregion, malaria elimination in the WHO European Region, and the ongoing process to update malaria terminology. Other topics on the agenda include G6PD testing before treatment and the latest updates on the RTS,S vaccine candidate.
27 August 2015 – Early and accurate diagnosis of malaria is essential to appropriately target treatment and guide management of febrile illnesses. Access to rapid diagnostic tests (RDTs), one of the two WHO-recommended methods for testing suspected malaria cases, is increasing worldwide. Between 2008 and 2013, the volume of RDT sales in endemic countries rose from 46 to 319 million, making the production and selection of high-quality RDT a critical process. This new section provides guidance for organizations and individuals considering the use of RDTs, as well as for malaria control programmes, health services and test kit manufacturers.
WHO commends RBM Partnership’s contribution to global progress as governing board disbands secretariat
25 August 2015 – The Roll Back Malaria (RBM) Partnership, established in 1998 as part of a global drive to galvanize stronger action to curb malaria, is to restructure to meet the new challenges posed in the post-2015 era whilst building on the success of the last 17 years. In light of this restructuring and continued financial difficulties, the governing board has recommended disbanding the current RBM secretariat hosted by WHO in Geneva.